- Home
- RNA vs CBT Comparison
RNA vs CBT Comparison
Compare RNA & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- CBT
- Stock Information
- Founded
- RNA 2012
- CBT 2019
- Country
- RNA United States
- CBT United States
- Employees
- RNA N/A
- CBT N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- CBT Major Chemicals
- Sector
- RNA Health Care
- CBT Industrials
- Exchange
- RNA Nasdaq
- CBT Nasdaq
- Market Cap
- RNA 4.0B
- CBT 3.9B
- IPO Year
- RNA 2020
- CBT N/A
- Fundamental
- Price
- RNA $46.92
- CBT $78.19
- Analyst Decision
- RNA Strong Buy
- CBT Hold
- Analyst Count
- RNA 15
- CBT 3
- Target Price
- RNA $68.40
- CBT $92.33
- AVG Volume (30 Days)
- RNA 3.7M
- CBT 406.8K
- Earning Date
- RNA 08-07-2025
- CBT 08-04-2025
- Dividend Yield
- RNA N/A
- CBT 2.19%
- EPS Growth
- RNA N/A
- CBT N/A
- EPS
- RNA N/A
- CBT 7.65
- Revenue
- RNA $10,729,000.00
- CBT $3,815,000,000.00
- Revenue This Year
- RNA N/A
- CBT N/A
- Revenue Next Year
- RNA $196.18
- CBT $3.32
- P/E Ratio
- RNA N/A
- CBT $10.72
- Revenue Growth
- RNA 1.23
- CBT N/A
- 52 Week Low
- RNA $21.51
- CBT $70.41
- 52 Week High
- RNA $56.00
- CBT $117.46
- Technical
- Relative Strength Index (RSI)
- RNA 71.22
- CBT 56.60
- Support Level
- RNA $45.06
- CBT $78.57
- Resistance Level
- RNA $47.24
- CBT $82.27
- Average True Range (ATR)
- RNA 2.58
- CBT 2.21
- MACD
- RNA 0.50
- CBT 0.54
- Stochastic Oscillator
- RNA 81.95
- CBT 79.26
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About CBT Cabot Corporation
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.